1
2
3
We don't have analytics for this instrument yet. You can contribute!
Please log in and be the first author to write an article about this instrument!
Novavax, Inc. (NASDAQ)
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Sessione trading (UTC)
Aperta ora
Chiusa ora
Chiude
Apre
alle
-
Gli orari di apertura sono indicati nel tuo fuso orario locale
(UTC)
Ticker | NVAX |
Valore del contratto | 100 shares |
Leva massima | 1:5 |
Storico degli swap
Data | Short Swap (%) | Long Swap (%) | No data |
---|
Volume minimo di una transazione | 0.01 lotto |
Volume massimo di una transazione | 100 lotti |
Margine di copertura | 50% |